LEGN in the 13F filings
Legend Biotech Corp · CUSIP 52490G102
- Quarter end
- 31 Dec 2023
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 8 Feb 2024
- Managers listing it
- 11
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q3 2023 and Q4 2023; 9 listed it in both
- Shares listed
- 34,907,169
- combined, among listed positions
- Reported value
- $2.1bn
- combined, at the quarter end
Among the 93 comparable managers: 6 buyers (opened or added shares) and 5 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing LEGN in Q4 2023
11 of 11 holders
Largest increases and reductions, by shares
Increases
- T. Rowe Price Associates Incexisting position · 10,808,216 shares now+1,114,848
- Holocene Advisors LPexisting position · 1,760,697 shares now+491,433
- Janus Henderson Group Ltdexisting position · 1,865,157 shares now+131,379
- MFS Investment Managementexisting position · 1,984,826 shares now+117,794
- Hudson Bay Capital Management LPnew position · 50,000 shares now+50,000
Reductions
- Fidelity (FMR LLC)existing position · 12,797,994 shares now-3,107,454
- Artisan Partners LPexisting position · 517,837 shares now-43,435
- Bridgewater Associates LPexisting position · 330,091 shares now-22,000
- Capital World Investorsexisting position · 2,385,960 shares now-1,872
New positions and exits
New (1)
Exited (1)
- Soros Fund Management LLCwas $6.0m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2020 | 4 | $159m | n.a. | n.a. |
| Q3 2020 | 2 | $116m | n.a. | n.a. |
| Q4 2020 | 3 | $123m | n.a. | n.a. |
| Q1 2021 | 4 | $170m | n.a. | n.a. |
| Q2 2021 | 4 | $178m | n.a. | n.a. |
| Q3 2021 | 5 | $387m | n.a. | n.a. |
| Q4 2021 | 6 | $401m | n.a. | n.a. |
| Q1 2022 | 7 | $338m | n.a. | n.a. |
| Q2 2022 | 9 | $993m | n.a. | n.a. |
| Q3 2022 | 8 | $847m | n.a. | n.a. |
| Q4 2022 | 9 | $1.1bn | n.a. | n.a. |
| Q1 2023 | 10 | $1.2bn | n.a. | n.a. |
| Q2 2023 | 11 | $2.5bn | n.a. | n.a. |
| Q3 2023 | 12 | $2.4bn | n.a. | n.a. |
| Q4 2023 | 11 | $2.1bn | 6 | 5 |
| Q1 2024 | 10 | $2.1bn | 5 | 4 |
| Q2 2024 | 8 | $1.6bn | 5 | 4 |
| Q3 2024 | 9 | $1.8bn | 7 | 2 |
| Q4 2024 | 10 | $523m | 6 | 4 |
| Q1 2025 | 8 | $916m | 4 | 4 |
| Q2 2025 | 6 | $1.1bn | 6 | 0 |
| Q3 2025 | 5 | $1.1bn | 5 | 0 |
| Q4 2025 | 6 | $679m | 14 | 11 |
| Q1 2026 | 4 | $155m | 15 | 9 |
| Q2 2026 | 5 | $1.0bn | 9 | 13 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
LEGN and LLY →LEGN and JNJ →LEGN and VRTX →Choose a stock to compare with LEGN →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own LEGN, latest filings →Back to the 13F Explorer →